Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.11 USD | +1.44% | -3.21% | -36.64% |
05-13 | Truist Securities Trims Price Target on Coherus BioSciences to $7 From $8, Maintains Buy Rating | MT |
05-09 | Transcript : Coherus BioSciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.64% | 242M | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.96% | 21.97B | |
-5.34% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- UBS Adjusts Coherus BioSciences Price Target to $7 From $11, Maintains Buy Rating